Campath (alemtuzumab) - Sanofi
fludarabine IV - Generic mfg.
melphalan - Generic mfg.
thiotepa - Generic mfg.
Immune Disorder HSCT Protocol (clinicaltrials.gov) - Oct 28, 2026 - P2 | N=28 | Completed | Sponsor: Washington University School of Medicine | Active, not recruiting ➔ Completed | N=20 ➔ 28 
Enrollment change • Trial completion • Bone Marrow Transplantation • Genetic Disorders • Hemophagocytic lymphohistiocytosis • Immunology • Primary Immunodeficiency • Rare Diseases • Transplantation
http://clinicaltrials.gov/ct2/show/NCT01821781
 
Oct 28, 2026
 
Prev Next